期刊文献+

肠易激综合症的人格特征及心理健康影响因素 被引量:8

The Personality and Influencing Factor of Mental Health for Irritable Bowel Syndrome.
下载PDF
导出
摘要 目的从心理学的角度出发,探讨肠易激综合症(IBS)患者心理健康的程度及其独特的人格特点。方法选取64例IBS患者和64例正常人作为研究对象,使用症状自评量表(SCL-90)和艾森克人格问卷,研究IBS患者心理健康的影响因素,及其与正常人人格之间的差异。结果 IBS患者的躯体化、敌对、精神病性、人际敏感、抑郁、焦虑和恐怖因子分显著高于正常人(t=2.76~7.26,P<0.05)。除恐怖因子外(F=3.18,P<0.05),不同年龄的IBS的SCL-90得分无明显差异。而女性的躯体化因子分明显高于男性(F=3.04,P<0.05)。而人格测验结果显示IBS患者精神质P、神经质N和掩饰性L得分均明显高于正常人(t=4.45~7.12,P<0.01),内外向E得分显著低于正常人(t=3.51,P<0.01)。结论 IBS患者的人格出现明显的异常,其精神质、神经质和掩饰性得分显著比正常人高,而且其心理健康水平总体偏低。 Objective To investigate the level of mental health and specific personality of patients with irritable bowel syndrone.Methods A total of 64 IBS patients and 64 normal people were selected randomly to investigate the difference of mental health and personality by the use of SCL-90 and Eysenck Personality Questionare.Results Somatization,hostility,psychoticism,interpersonal sensitivity,depression,anxiety and phobia were significantly higher in patients with IBS than in normal people(t=2.76~7.26,P0.05),and different ages(F=0.58~2.09,P0.05) had no significant difference except for the phobia(F=3.18,P0.05).Somatization in women was significant higher than that in men(F=3.04,P0.05).The EPQ test revealed that the psychoticism,nervousness and lie were significantly higher than the normal people(t=4.45~7.12,P0.01),and the extraversion was significantly lower than the normal people(t=3.51,P0.01).Conclusion The IBS patients show abnormal personnality with high score of psychosis,nervousness,and lies,and these patients have poor mental health level.
出处 《中国健康心理学杂志》 2013年第8期1165-1167,共3页 China Journal of Health Psychology
关键词 肠易激综合症 人格 艾森克人格问卷 症状自评量表 Irritable bowel syndrome Personality EPQ SCL-90
  • 相关文献

参考文献4

二级参考文献51

  • 1欧阳钦,易智慧.功能性肠病研究进展[J].国外医学(消化系疾病分册),2005,25(2):67-69. 被引量:26
  • 2汪向东.心理卫生评定量表手册[J].中国心理卫生杂志,1993,:202-209.
  • 3王征宇.症状自评量表(SCL-90)[J].上海精神医学,1984,4(2):67-68.
  • 4金华 吴文源.中国正常人SCL-90评定结果的初步分析[J].中国神经精神疾病杂志,1986,12(5):68-70.
  • 5[1]Lauer GM,Walker BD.Hepatitis C virus infection.N Engl J Med 2001; 345:41-52.
  • 6[2]Alter MJ,Kruszon-Moran D,Nainan OV,McQuillan GM,Gao F,Moyer LA,Kaslow RA,Margolis HS.The prevalence of hepatitis C virus infection in the United States,1988 through 1994.N Engl J Med 1999; 341:556-562
  • 7[3]Curry MP.Hepatitis B and hepatitis C viruses in liver transplantation.Transplantation 2004; 78:955-963
  • 8[4]Vargas HE,Laskus T,Radkowski M,Wilkinson J,Balan V,Douglas DD,Harrison ME,Mulligan DC,Olden K,Adair D,Rakela J.Detection of hepatitis C virus sequences in brain tissue obtained in recurrent hepatitis C after liver transplantation.Liver Transpl 2002; 8:1014-1019
  • 9[5]Yan FM,Chen AS,Hao F,Zhao XP,Gu CH,Zhao LB,Yang DL,Hao LJ.Hepatitis C virus may infect extrahepatic tissues in patients with hepatitis C.World J Gastroenterol 2000; 6:805-811
  • 10[6]Lamelin JP,Zoulim F,Trepo C.Lymphotropism of hepatitis B and C viruses:an update and a newcomer.Int J Clin Lab Res 1995; 25:1-6

共引文献654

同被引文献75

  • 1赵幸福,张亚林,李龙飞,周云飞,李鹤展,杨世昌.中文版儿童期虐待问卷的信度和效度[J].中国临床康复,2005,9(20):105-107. 被引量:339
  • 2Lee SH, Kim KN, Kim KM, et al. Irritable Bowel Syndrome May Be Associated with Elevated Alanine Aminotransferase and, Metabolic Syndrome[ J]. Yonsei Medical Journal,2016,57 ( 1 ) : 146-152.
  • 3Thijssen AY, Clemens CH, Vankerckhoven V, et al. Efficacy of Lactobacillus casei Shimta for patients with irritable bowel syn- drome[ J]. Eur J Gastroenterol Hepato1,2016 ,28 ( 1 ) :8-14.
  • 4Zhou X, Dong L, Yang B, et al. Preinduction of heat shock protein 70 protects mice against post-infection irritable bowel syndrome via NF-kB and NOS/NO signaling pathways[ J]. Amino Acids,2015, 47(12) :2635-2645.
  • 5修玮.胃肠解痉药的药物分析[J].中外健康文摘,2013,10(21):117-118.
  • 6Chey WD, Eswaran S, Kurlander J. JAMA patient page. Irritable bowel syndrome. JAMA 2015; 313:982 [PMID: 25734751 DOI: 10.1001/ jama.2015.0958].
  • 7Lj6tsson B, Andersson G, Andersson E, Hedman E, Lindfors P, Andr6ewitch S, Riick C, Lindefors N. Acceptability, effectiveness, and cost-effectiveness of internet-based exposure treatment for irritable bowel syndrome in a clinical sample: a randomized controlled trial. BMC Gastroenterol 2011; 11:110 [PMID: 21992655 DOI: 10,1186/1471- 230X-11-110].
  • 8Sonneveld P, Verelst SG, Lewis P, Gray-Schopfer V, Hutchings A, Nixon A, Petrucci MT. Review of health-related quality of life data in multiple myeloma patients treated with novel agents. Leukemia 2013; 27:1959-1969 [PMID: 23783393 DOI: 10.1038/ieu.2013.185].
  • 9Makker J, Chilimuri S, Bella JN. Genetic epidemiology of irritable bowel syndrome. World ] Gastroenterol 2015; 21:11353-11361 [PMID: 26525775 DOI: 10.3748/wjg.v21.i40.11353].
  • 10Rusu F, Dumitrascu DL. Epidemiology of irritable bowel syndrome in the former communist countries from Eastern Europe: a systematic review. Clujul Med 2015; 88:146-151 [PMID: 26528063 DOI: 10.15386/cjmed-449].

引证文献8

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部